BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22215658)

  • 1. Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.
    Serie K; Fukuda N; Nakai S; Matsuda H; Maruyama T; Murayama Y; Omata S
    Perit Dial Int; 2012; 32(4):462-72. PubMed ID: 22215658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery.
    Yao EH; Fukuda N; Ueno T; Matsuda H; Nagase H; Matsumoto Y; Sugiyama H; Matsumoto K
    Cardiovasc Res; 2009 Mar; 81(4):797-804. PubMed ID: 19098300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional inhibition of hypertrophic scars by a gene silencer, pyrrole-imidazole polyamide, targeting the TGF-β1 promoter.
    Washio H; Fukuda N; Matsuda H; Nagase H; Watanabe T; Matsumoto Y; Terui T
    J Invest Dermatol; 2011 Oct; 131(10):1987-95. PubMed ID: 21654833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.
    Abrahams AC; Habib SM; Dendooven A; Riser BL; van der Veer JW; Toorop RJ; Betjes MG; Verhaar MC; Watson CJ; Nguyen TQ; Boer WH
    PLoS One; 2014; 9(11):e112050. PubMed ID: 25384022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel gene silencer pyrrole-imidazole polyamide targeting human connective tissue growth factor.
    Wan JX; Fukuda N; Ueno T; Watanabe T; Matsuda H; Saito K; Nagase H; Matsumoto Y; Matsumoto K
    Biol Pharm Bull; 2011; 34(10):1572-7. PubMed ID: 21963497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
    Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
    J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of TGF-β1 and Effects of Gene Silencer Pyrrole-Imidazole Polyamides Targeting TGF-β1 in Diabetic Nephropathy.
    Horikoshi S; Fukuda N; Tsunemi A; Okamura M; Otsuki M; Endo M; Abe M
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32093382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset.
    Otsuki M; Fukuda N; Inoue T; Mineshige T; Otsuki T; Horikoshi S; Endo M; Abe M
    Molecules; 2019 Sep; 24(17):. PubMed ID: 31480595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-β1.
    Saito K; Fukuda N; Shinohara K; Masuhiro Y; Hanazawa S; Matsuda H; Fujiwara K; Ueno T; Soma M
    Int J Biochem Cell Biol; 2015 Sep; 66():112-20. PubMed ID: 26222185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter.
    Matsuda H; Fukuda N; Ueno T; Katakawa M; Wang X; Watanabe T; Matsui S; Aoyama T; Saito K; Bando T; Matsumoto Y; Nagase H; Matsumoto K; Sugiyama H
    Kidney Int; 2011 Jan; 79(1):46-56. PubMed ID: 20861821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA binding properties of novel gene silencing pyrrole-imidazole polyamides.
    Iguchi A; Fukuda N; Takahashi T; Watanabe T; Matsuda H; Nagase H; Bando T; Sugiyama H; Shimizu K
    Biol Pharm Bull; 2013; 36(7):1152-8. PubMed ID: 23628892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of gene therapy for encapsulating peritoneal sclerosis by a chimeric DNA-RNA hammerhead ribozyme targeting TGF-beta1 mRNA].
    Maruyama N; Fukuda N; Okada K; Matsumoto K
    Nihon Jinzo Gakkai Shi; 2007; 49(2):113-20. PubMed ID: 17375619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
    Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
    BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
    Hong M; Nie Z; Chen Z; Yu X; Bao B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged peritoneal gene expression using a helper-dependent adenovirus.
    Liu L; Shi CX; Ghayur A; Zhang C; Su JY; Hoff CM; Margetts PJ
    Perit Dial Int; 2009; 29(5):508-16. PubMed ID: 19776043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic pyrrole-imidazole polyamide inhibits expression of the human transforming growth factor-beta1 gene.
    Lai YM; Fukuda N; Ueno T; Matsuda H; Saito S; Matsumoto K; Ayame H; Bando T; Sugiyama H; Mugishima H; Serie K
    J Pharmacol Exp Ther; 2005 Nov; 315(2):571-5. PubMed ID: 16120815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Study of Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Hypertrophic Scars in a Common Marmoset Primate Model.
    Igarashi J; Fukuda N; Inoue T; Nakai S; Saito K; Fujiwara K; Matsuda H; Ueno T; Matsumoto Y; Watanabe T; Nagase H; Bando T; Sugiyama H; Itoh T; Soma M
    PLoS One; 2015; 10(5):e0125295. PubMed ID: 25938472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats.
    Hur E; Bozkurt D; Timur O; Bicak S; Sarsik B; Akcicek F; Duman S
    Clin Nephrol; 2012 Jan; 77(1):1-7. PubMed ID: 22185962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.
    Washida N; Wakino S; Tonozuka Y; Homma K; Tokuyama H; Hara Y; Hasegawa K; Minakuchi H; Fujimura K; Hosoya K; Hayashi K; Itoh H
    Nephrol Dial Transplant; 2011 Sep; 26(9):2770-9. PubMed ID: 21378147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.